United Asset Strategies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$645K Buy
26,793
+1,301
+5% +$34K 0.05% 189
2026
Q1
$716K Buy
25,492
+892
+4% +$23.7K 0.06% 172
2025
Q4
$613K Sell
24,600
-219
-0.9% -$5.52K 0.05% 182
2025
Q3
$632K Buy
24,819
+143
+0.6% +$3.53K 0.05% 180
2025
Q2
$598K Sell
24,676
-355
-1% -$8.28K 0.05% 179
2025
Q1
$634K Sell
25,031
-6,307
-20% -$165K 0.06% 176
2024
Q4
$831K Sell
31,338
-936
-3% -$25.4K 0.08% 146
2024
Q3
$934K Buy
32,274
+2,141
+7% +$62.5K 0.09% 145
2024
Q2
$843K Sell
30,133
-175
-0.6% -$4.82K 0.08% 145
2024
Q1
$841K Sell
30,308
-18,097
-37% -$502K 0.08% 160
2023
Q4
$1.39M Sell
48,405
-15,681
-24% -$474K 0.16% 120
2023
Q3
$2.13M Sell
64,086
-38,950
-38% -$1.38M 0.27% 82
2023
Q2
$3.78M Buy
103,036
+4,959
+5% +$193K 0.47% 58
2023
Q1
$4M Buy
98,077
+5,789
+6% +$250K 0.53% 54
2022
Q4
$4.73M Buy
92,288
+6,900
+8% +$331K 0.66% 51
2022
Q3
$3.74M Buy
85,388
+4,713
+6% +$229K 0.57% 57
2022
Q2
$4.23M Buy
80,675
+3,844
+5% +$196K 0.62% 51
2022
Q1
$3.98M Sell
76,831
-57,459
-43% -$2.98M 0.51% 55
2021
Q4
$7.93M Sell
134,290
-1,835
-1% -$90.9K 0.94% 40
2021
Q3
$5.86M Sell
136,125
-905
-0.7% -$40.1K 0.76% 46
2021
Q2
$5.37M Buy
137,030
+5,577
+4% +$217K 0.72% 47
2021
Q1
$4.76M Sell
131,453
-2,409
-2% -$85.5K 0.69% 47
2020
Q4
$4.93M Buy
133,862
+26,842
+25% +$985K 0.77% 45
2020
Q3
$3.73M Buy
107,020
+39,605
+59% +$1.39M 0.69% 47
2020
Q2
$2.09M Buy
67,415
+6,048
+10% +$205K 0.41% 60
2020
Q1
$1.9M Sell
61,367
-2,016
-3% -$68.7K 0.47% 55
2019
Q4
$2.36M Buy
63,383
+1,082
+2% +$38.5K 0.46% 64
2019
Q3
$2.12M Sell
62,301
-45,593
-42% -$1.66M 0.46% 64
2019
Q2
$4.43M Buy
107,894
+13,999
+15% +$556K 1.02% 35
2019
Q1
$3.78M Buy
93,895
+28,577
+44% +$1.14M 0.89% 39
2018
Q4
$2.71M Sell
65,318
-3,126
-5% -$130K 0.74% 45
2018
Q3
$2.86M Sell
68,444
-1,039
-1% -$40K 0.67% 52
2018
Q2
$2.39M Sell
69,483
-6,378
-8% -$218K 0.63% 53
2018
Q1
$2.55M Sell
75,861
-859
-1% -$29.5K 0.75% 43
2017
Q4
$2.64M Sell
76,720
-146
-0.2% -$4.98K 0.71% 44
2017
Q3
$2.6M Sell
76,866
-8,243
-10% -$265K 1.48% 22
2017
Q2
$2.71M Buy
85,109
+2,479
+3% +$78.2K 0.8% 42
2017
Q1
$2.68M Buy
82,630
+2,675
+3% +$84.3K 0.82% 40
2016
Q4
$2.46M Buy
79,955
+8,381
+12% +$256K 0.8% 43
2016
Q3
$2.28M Buy
71,574
+1,959
+3% +$65.5K 0.8% 43
2016
Q2
$2.33M Sell
69,615
-100
-0.1% -$3.19K 0.87% 41
2016
Q1
$1.96M Buy
69,715
+7,175
+11% +$205K 0.87% 37
2015
Q4
$1.92M Buy
62,540
+146
+0.2% +$4.59K 0.83% 40
2015
Q3
$1.86M Buy
62,394
+1,752
+3% +$56.2K 0.86% 40
2015
Q2
$1.93M Buy
60,642
+1,947
+3% +$63.5K 0.86% 45
2015
Q1
$1.89M Sell
58,695
-9,879
-14% -$314K 0.88% 43
2014
Q4
$2.03M Buy
68,574
+3,609
+6% +$103K 0.87% 45
2014
Q3
$1.82M Sell
64,965
-4,867
-7% -$137K 0.82% 50
2014
Q2
$1.97M Sell
69,832
-62,067
-47% -$1.77M 0.95% 41
2014
Q1
$4.02M Buy
131,899
+25,727
+24% +$767K 2.28% 12
2013
Q4
$3.08M Buy
106,172
+16,580
+19% +$483K 2.12% 13
2013
Q3
$2.44M Buy
89,592
+1,912
+2% +$52K 1.55% 21
2013
Q2
$2.33M Buy
+87,680
New +$2.42M 1.54% 22

Other funds holding PFE

United Asset Strategies's PFE Position: Q2 2026 in Review

United Asset Strategies increased its Pfizer (PFE) stake by 5.1% in Q2 2026, buying an estimated $34K and bringing the position to 26,793 shares worth $645K. The position accounts for 0.05% of the portfolio, ranked #189.

United Asset Strategies first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.93M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • United Asset Strategies held 26,793 shares of Pfizer worth $645K as of Q2 2026.
  • United Asset Strategies bought 1,301 Pfizer shares in Q2 2026, an estimated $34K.
  • Pfizer made up 0.05% of United Asset Strategies's portfolio in Q2 2026, its #189 holding.
  • United Asset Strategies first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • United Asset Strategies's Pfizer position peaked at $7.93M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on United Asset Strategies's 13F filing for Q2 2026, filed 13 Jul 2026.